Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06626841
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-29
Brief Title:
Assessment of Pelvic Floor Strength Variables in Female Nulliparous Athletes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Functional Fitness Training Workout Significantly Affects Pelvic Floor Strength and Muscle Activation in Female Nulliparous Athletes
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FFT-PFM
Brief Summary:
Functional Fitness Training FFT is a modality that seeks to improve physical fitness and performance within several functional tasks by conducting a variety of training activities such as aerobic and metabolic conditioning resistance training and high impact exercises Although there are many benefits of FFT for improving fitness and body composition their effects on the pelvic floor are not clear as high-impact exercises performed in FFT have been shown to cause an increase in intra-abdominal pressure When these exercises are performed repeatedly fatigue can occur within the pelvic floor muscles PFM which can increase the risk of developing pelvic floor dysfunctions However currently little is known about how FFT activities acutely affect the PFM and whether such training regimes may contribute to long-term urinary incontinence in female FFT athletes Therefore this study aimed to analyse the acute effects of a FFTworkout on pelvic floor strength and muscle activation in nulliparous female FFT athletes It is hypothesized that both strength and PFM activation of the female athletes would be reduced after a FFT workout due to PFM fatigue
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None